Shares in Britain's AstraZeneca fell over 2% in early trades on Monday (June 8).
After a report from
Class="kln">Bloombergsuggested it had approached U.S. rival Gilead Sciences about a possible merger.
A union would create one of the world's largest drug companies.
And together, the two companies would have a market capitalisation of around $232 billion.
It would also unite two drugmakers at the forefront of efforts to fight the new coronavirus.
But that could be politically complicated as governments seek control over potential treatments.
And there were some raised eyebrows over the report on Monday.
One analyst questioned why the British group would seek to tie up with a company that is growing at a slower pace.
The report by Bloomberg said AstraZeneca contacted Gilead last month, but that its U.S. rival was not interested in combining with another big pharmaceuticals company.
Early research has shown that one of Astra's cancer drugs may help hospitalised patients get through the worst of Covid-19.
And Gilead Science's antiviral drug remdesivir has proven to provide a modest benefit to some patients with moderate symptoms of the illness.
💡 newsR Knowledge: Other News Mentions
Europe Inc. plunges into the red
Credit: Reuters Studio Duration: 01:37Published
Sanofi eyes vaccine approval by early 2021
Credit: Reuters Studio Duration: 01:13Published
Drugmaker Says Remdesivir Can Lower COVID-19 Death Risk By 62%
Credit: Wochit News Duration: 00:32Published
Gilead sparks Wall Street rally
Credit: Reuters Studio Duration: 01:20Published
Gilead says remdesivir cuts death risk
Credit: Reuters Studio Duration: 01:04Published
Gilead's remdesivir gets conditional EU clearance
Credit: Reuters Studio Duration: 00:59Published
Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment
Credit: Wochit News Duration: 00:35Published
Israel Embassy contributes AI-based technologies to the AIIMS Delhi
Credit: ANI Duration: 01:58Published
Have to see critically whether it is safe, effective: AIIMS Director on Russia's COVID-19 vaccine
Credit: ANI Duration: 01:06Published
India expresses interest in Russia's COVID-19 vaccineThe statement on the website dedicated to the "world's first registered Covid-19 vaccine" lists out India along with 20 other countries that have shown interest..
Paddleboarding Festival in Russia Draws Thousands, COVID Nightmare on WaterRussia beat the U.S. into orbit in the '60s, and might have thought they beat us in COVID-safe fun -- but looking at these images of paddleboarders packed..
Centre's help in providing Covid test kits to UP must continue: Adityanath to PMThe chief minister also sought the Centre's support for purchasing HFNC equipment, used in giving high flow nasal oxygen to patients. Adityanath also apprised..
You Might Like
Related news from verified sources
Tweets about this